+

WO2000063378A3 - Zalpha13: proteine humaine secretee - Google Patents

Zalpha13: proteine humaine secretee Download PDF

Info

Publication number
WO2000063378A3
WO2000063378A3 PCT/US2000/010466 US0010466W WO0063378A3 WO 2000063378 A3 WO2000063378 A3 WO 2000063378A3 US 0010466 W US0010466 W US 0010466W WO 0063378 A3 WO0063378 A3 WO 0063378A3
Authority
WO
WIPO (PCT)
Prior art keywords
zalpha13
secreted protein
human secreted
provides
proteins
Prior art date
Application number
PCT/US2000/010466
Other languages
English (en)
Other versions
WO2000063378A2 (fr
Inventor
Darrell C Conklin
Zeren Gao
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Priority to JP2000612457A priority Critical patent/JP2002541848A/ja
Priority to AU44694/00A priority patent/AU4469400A/en
Priority to EP00926112A priority patent/EP1171600A2/fr
Publication of WO2000063378A2 publication Critical patent/WO2000063378A2/fr
Publication of WO2000063378A3 publication Critical patent/WO2000063378A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Les protéines sécrétées assurent beaucoup de fonctions essentielles au métabolisme et à la différenciation cellulaire. Cette classe de protéines fournit donc souvent des substances pharmaceutiques thérapeutiquement utiles. L'invention concerne une nouvelle protéine humaine sécrétée, appelée Zalpha13.
PCT/US2000/010466 1999-04-20 2000-04-18 Zalpha13: proteine humaine secretee WO2000063378A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2000612457A JP2002541848A (ja) 1999-04-20 2000-04-18 Ｚａｌｐｈａ１３：ヒト分泌性タンパク質
AU44694/00A AU4469400A (en) 1999-04-20 2000-04-18 Zalpha13: a human secreted protein
EP00926112A EP1171600A2 (fr) 1999-04-20 2000-04-18 Zalpha13: proteine humaine secretee

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29497299A 1999-04-20 1999-04-20
US09/294,972 1999-04-20

Publications (2)

Publication Number Publication Date
WO2000063378A2 WO2000063378A2 (fr) 2000-10-26
WO2000063378A3 true WO2000063378A3 (fr) 2001-01-18

Family

ID=23135707

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/010466 WO2000063378A2 (fr) 1999-04-20 2000-04-18 Zalpha13: proteine humaine secretee

Country Status (4)

Country Link
EP (1) EP1171600A2 (fr)
JP (1) JP2002541848A (fr)
AU (1) AU4469400A (fr)
WO (1) WO2000063378A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006423A1 (fr) * 1997-07-30 1999-02-11 Human Genome Sciences, Inc. 83 proteines humaines secretees
WO1999014230A1 (fr) * 1997-09-18 1999-03-25 Washington University La mammaglobine, proteine secretee du cancer du sein specifique de la glande mammaire

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006423A1 (fr) * 1997-07-30 1999-02-11 Human Genome Sciences, Inc. 83 proteines humaines secretees
WO1999014230A1 (fr) * 1997-09-18 1999-03-25 Washington University La mammaglobine, proteine secretee du cancer du sein specifique de la glande mammaire

Also Published As

Publication number Publication date
JP2002541848A (ja) 2002-12-10
WO2000063378A2 (fr) 2000-10-26
EP1171600A2 (fr) 2002-01-16
AU4469400A (en) 2000-11-02

Similar Documents

Publication Publication Date Title
AU4010400A (en) 27 human secreted proteins
AU1604401A (en) 18 human secreted proteins
AU1448701A (en) 15 human secreted proteins
AU1334101A (en) 19 human secreted proteins
AU4072000A (en) 62 human secreted proteins
AU3769700A (en) 45 human secreted proteins
AU2757500A (en) 33 human secreted proteins
AU1918601A (en) 23 human secreted proteins
AU3517000A (en) 50 human secreted proteins
AU3628600A (en) 46 human secreted proteins
AU1342501A (en) 32 human secreted proteins
AU3249300A (en) 47 human secreted proteins
WO2000063378A3 (fr) Zalpha13: proteine humaine secretee
AU4018100A (en) 49 human secreted proteins
AU1449001A (en) 28 human secreted proteins
WO2003044185A3 (fr) Nouveaux polypeptides purifies iimpliques dans un metabolisme general
AU3628700A (en) 49 human secreted proteins
AU3908600A (en) 50 human secreted proteins
AU3871300A (en) 50 human secreted proteins
AU1438201A (en) 25 human secreted proteins
AU3529000A (en) 47 human secreted proteins
AU1472701A (en) 28 human secreted proteins
AU3747000A (en) 49 human secreted proteins
AU3730500A (en) 50 human secreted proteins
AU1655701A (en) 15 human secreted proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2000926112

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 612457

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2000926112

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000926112

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载